Our Bureau, Mumbai Thursday, October 17, 2024, 16:30 Hrs [IST] ...

Our Bureau, Bengaluru Thursday, October 17, 2024, 16:15 Hrs [IST] ...

Immuneering Corporation’s drug candidate IMM-1-104 receives US FDA orphan drug designation for treatment of pancreatic cancer: Cambridge, Massachusetts Thursday, October 17, 202 ...

Gennet Lab and Estonian Embassy inks pact with Sterlite Technologies for healthcare solutions: Our Bureau, Bengaluru Thursday, October 17, 2024, 15:40 Hrs [IST] Gennet Lab, one of ...

NIH funded study finds Alzheimer’s disease may damage the brain in two phases: Bethesda, Maryland Thursday, October 17, 2024, 15:30 Hrs [IST] Alzheimer’s disease may damage th ...

Johnson & Johnson announces positive results from phase 2/3 Vibrance-MG study of nipocalimab in adolescents living with generalized myasthenia gravis: Savannah, Georgia Thursday, ...

Secaucus, New Jersey Thursday, October 17, 2024, 14:00 Hrs [IST] ...

L V Prasad Eye Institute founder highlights creation of infrastructure for corneal transplants in India: Our Bureau, Bengaluru Thursday, October 17, 2024, 13:30 Hrs [IST] Dr Gulla ...

Vaxart to present norovirus data at IDWeek 2024 underscoring commitment to address significant unmet need: South San Francisco, California Thursday, October 17, 2024, 13:00 Hrs [I ...

Micro Labs acquires Swipha, to strengthen its presence in Nigeria, Africa: Our Bureau, Bengaluru Thursday, October 17, 2024, 12:45 Hrs [IST] Micro Labs, Karnataka’s pharma major ...

NIH & US FDA leaders call for innovation in development of smoking cessation treatments: Bethesda, Maryland Thursday, October 17, 2024, 12:00 Hrs [IST] In a new commentary in the ...

Hoth Therapeutics receives US patent for its pioneering Alzheimer's treatment, HT-ALZ: New York Thursday, October 17, 2024, 11:00 Hrs [IST] Hoth Therapeutics, Inc., a clinical-sta ...